GLP-1 medications have transformed the treatment of obesity and metabolic disease. The primary goal of medical weight loss is to improve health outcomes by achieving and maintaining a healthy body weight. However, GLP-1 therapies appear to produce improvements in metabolic markers that extend beyond what would typically be expected from weight loss alone. For this reason, when used appropriately, these medications have become an important tool in addressing the current burden of metabolic disease.
To optimise both treatment effectiveness and long-term health outcomes, the use of GLP-1 medications should be accompanied by a deliberate and structured approach to fat loss. Understanding how these therapies work highlights why this intentional strategy, particularly with regard to nutrition, is so important. GLP-1 medications regulate appetite, slow gastric emptying, and improve blood glucose control. These effects naturally lead to reduced caloric intake and improvements in cardiometabolic health. However, because appetite is significantly suppressed, overall food intake (and therefore nutrient intake) often declines as well.
When hunger decreases, the nutritional quality of the diet becomes even more important. Individuals must ensure that adequate amounts of protein, micronutrients, and essential fatty acids are still consumed despite eating less. In this context, intentional nutrition plays a key role in protecting lean muscle mass, supporting metabolic function, and maintaining overall health as body fat is reduced.
While a healthy, balanced diet remains the foundation of good nutrition, targeted supplementation can provide additional support during periods of reduced caloric intake. When thoughtfully incorporated, supplements can help maintain nutrient adequacy and support overall health while using GLP-1 medications.
Key supplements to consider include:
Protein, e.g. a whey supplement
Adequate protein intake is essential for preserving lean muscle mass during weight loss, supporting metabolic rate, and promoting satiety.
Magnesium
Supports glucose metabolism, neuromuscular function, and sleep regulation. Suboptimal levels may contribute to fatigue, muscle cramps, and impaired insulin sensitivity.
Vitamin D3
Essential for bone health, immune function, and muscle function. Given the high global prevalence of deficiency, supplementation is often appropriate, particularly during weight loss.
Fibre
Reduced food intake often leads to inadequate fibre consumption. Supplementation can support gastrointestinal health, improve satiety, and assist with glycaemic control.
B Vitamins
Important for cellular energy production, neurological function, and red blood cell formation, helping maintain energy levels during periods of calorie restriction.
Omega-3 Fatty Acids (EPA/DHA)
Support cardiovascular health, help modulate inflammation, and may assist in preserving lean mass, particularly in individuals with elevated cardiometabolic risk.
Conclusion
GLP-1 therapies offer a powerful tool for improving metabolic health and supporting sustainable weight loss. However, their appetite-suppressing effects make it essential to approach nutrition with intention and care. Prioritising nutrient-dense foods, adequate protein intake, and targeted supplementation where appropriate can help ensure that reduced caloric intake does not compromise overall health. By combining medical therapy with thoughtful nutritional strategies, individuals can maximise the benefits of GLP-1 medications while protecting metabolic function, preserving lean mass, and supporting long-term wellbeing.